Acoustic Activation Imaging With Intravenous Perfluoropropane Nanodroplets Results in Selective Bioactivation of the Risk Area
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Shouqiang Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Fluorocarbons, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Acoustically activatable perfluoropropane droplets (PD) can be formulated from commercially available microbubble preparations. Diagnostic transthoracic ultrasound frequencies have resulted in acoustic activation (AA) predominately within myocardial infarct zones (IZ).
Objective
We hypothesized that the AA area following acute coronary ischemia/reperfusion (I/R) would selectively enhance the developing scar zone, and target bioeffects specifically to this region.
Methods
We administered intravenous PD in 36 rats and 20 pigs at various stages of myocardial scar formation (30 minutes, 1 day, and 7 days post I/R) to determine what effect infarct age had on the AA within the IZ. This was correlated with histology, myeloperoxidase activity, and tissue nitrite activity.
Results
The degree of AA within the IZ in rats was not associated with collagen content, neutrophil infiltration, or infarct age. AA within 24 hours of I/R was associated with increased nitric oxide utilization selectively within the IZ ( P < .05 compared with remote zone). The spatial extent of AA in pigs correlated with infarct size only when performed before sacrifice at 7 days ( r = .74, P < .01).
Conclusions
Acoustic activation of intravenous PD enhances the developing scar zone following I/R, and results in selective tissue nitric oxide utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- narnar.co, Lake Oswego, Oregon, USA.
- Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, USA.
- Department of Engineering, Swarthmore College, Swarthmore, Pennsylvania, USA.
ORCID-Profile: Thomas R Porter
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Li, S., Chen, C., Lof, J., Stolze, E. A., Sklenar, J., Chen, X., Pacella, J. J., Villanueva, F. S., Matsunaga, T. O., Everbach, E. C., Radio, S. J., Westphal, S. N., Shiva, S., Xie, F., Leng, X., & Porter, T. R. (2024). Acoustic Activation Imaging With Intravenous Perfluoropropane Nanodroplets Results in Selective Bioactivation of the Risk Area. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16435
Vancouver
Li S, Chen C, Lof J, Stolze EA, Sklenar J, Chen X, et al. Acoustic Activation Imaging With Intravenous Perfluoropropane Nanodroplets Results in Selective Bioactivation of the Risk Area. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16435
BibTeX
@article{Li2024,
author = {Li, Shouqiang and Chen, Cheng and Lof, John and Stolze, Elizabeth A and Sklenar, Jiri and Chen, Xucai and Pacella, John J and Villanueva, Flordeliza S and Matsunaga, Terry O and Everbach, E Carr and Radio, Stanley J and Westphal, Sherry N and Shiva, Sruti and Xie, Feng and Leng, Xiaoping and Porter, Thomas R},
title = {Acoustic Activation Imaging With Intravenous Perfluoropropane Nanodroplets Results in Selective Bioactivation of the Risk Area},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16435}
}
EUVIMED